Sun.Feb 25, 2024

article thumbnail

API industry is seeing robust action in leadership hiring space: Report

Express Pharma

For this report WalkWater researched 51 API companies and included 120 candidates at leadership level in manufacturing role WalkWater Talent Advisors, one of India’s top executive search firms has released a comprehensive report shedding light on key trends and talent insights which are driving leadership hiring in the manufacturing function in India’s Active Pharmaceutical Ingredient (API) industry.

article thumbnail

Rare Disease Day 2024 – The importance of shining a light on rare diseases

pharmaphorum

Rare Disease Day 2024 is an important opportunity to raise awareness about rare diseases and the need for research, diagnosis, and treatment options like orphan drugs. Learn the significance of shining a light on rare diseases.

104
104
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Cadila Pharma launches aqueous vitamin D injection

Express Pharma

Aqueous cholecalciferol injection offers a unique solution with rapid correction of vitamin D deficiency in a short span of time Cadila Pharma has announced the launch of the world’s first aqueous formulation of cholecalciferol for v itamin D deficiency. This innovation demonstrates superior pharmacokinetics (PK) and pharmacodynamics (PD) compared to traditional oil-based cholecalciferol preparations available in the market.

101
101
article thumbnail

Microbiology Laboratory Strategies to Advance Antimicrobial Stewardship

ID Stewardship

In this article four experts from bioMérieux discuss microbiology strategies to advance antimicrobial stewardship, reflecting on a recent Xchat (Twitter Chat) on the topic. Authored By: Katarzyna Wojcik, PMP, PhD, Andrea Prinzi, PhD, MPH, CPH, SM(ASCP), Amanda Suchanek, Ph.D., Jessica Blavignac There is no question that antimicrobial resistance (AMR) has created new challenges for all stakeholders, requiring active and continued collaboration between healthcare professionals and various discip

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

CymaBay's seladelpar has the potential to raise the bar in treatment for PBC

Outsourcing Pharma

Results from a phase 3 trial looking at treatment for primary biliary cholangitis (PBC) are 'genuinely exciting' and supports the potential for seladelpar to raise the bar in treatment of the disease.

82
article thumbnail

Interchangeable high-concentration Humira approved in US

pharmaphorum

TevaU and Alvotech claim first US approval for first biosimilar of AbbVie’s high-concentration Humira, which accounts for 88% of brand prescriptions

More Trending

article thumbnail

New patent expiration for Endo Pharms drug NASCOBAL

Drug Patent Watch

Annual Drug Patent Expirations for NASCOBAL Nascobal is a drug marketed by Par Pharm and Endo Pharms Inc and is included in two NDAs. It is available from one supplier.… The post New patent expiration for Endo Pharms drug NASCOBAL appeared first on DrugPatentWatch - Make Better Decisions.

59
article thumbnail

Health Canada disclosing more information on pending generic drug submissions

Pharma in Brief

On February 23, 2024, Health Canada published a Notice advising that it was making its review process for generic drug submissions more transparent. Specifically, for generic drug submissions accepted into review on or after April 1, 2024, Health Canada will start disclosing: (i) the year and month that the submission was accepted for review; and (ii) the company sponsoring the generic drug.

article thumbnail

New patent expiration for Almatica drug GRALISE

Drug Patent Watch

Annual Drug Patent Expirations for GRALISE Gralise is a drug marketed by Almatica and is included in one NDA. It is available from one supplier. There is one patent protecting… The post New patent expiration for Almatica drug GRALISE appeared first on DrugPatentWatch - Make Better Decisions.

59
article thumbnail

Free NAPLEX Osteoporosis Crossword Puzzle

Med Ed 101

I’m currently working on finishing up a big-time project for the NAPLEX exam. It is a crossword puzzle book that will help prepare you for the NAPLEX. I’m providing a free osteoporosis crossword puzzle as a sample of what this book will be like. There will be 100 puzzles and well over 2,000 practice questions […] The post Free NAPLEX Osteoporosis Crossword Puzzle appeared first on Med Ed 101.

52
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Which pharmaceutical companies have the most drug patents in Serbia?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most patents in Serbia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is… The post Which pharmaceutical companies have the most drug patents in Serbia? appeared first on DrugPatentWatch - Make Better Decisions.